| 378 |
397: Response, Keratinocytes |
398: Activation, Dendritic Cells |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 384 |
192: Altered, Neurophysiology |
402: Cognitive function, decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 396 |
408: reduction in ovarian granulosa cells, Aromatase (Cyp19a1) |
3: Reduction, 17beta-estradiol synthesis by ovarian granulosa cells |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 402 |
409: Metabolism of AFB1, Production of Reactive Electrophiles |
373: Formation, Pro-mutagenic DNA Adducts |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 411 |
228: demethylation, PPARg promoter |
54: Up Regulation, CD36 |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 432 |
444: Increased, Atrioventricular block and bradycardia |
351: Increased Mortality |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 443 |
425: Thyroidal Iodide, Decreased |
281: T4 in serum, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 454 |
10: ACh Synaptic Accumulation |
444: Increased, Atrioventricular block and bradycardia |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 547 |
493: Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts |
376: Increased, Induced Mutations in Critical Genes |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 549 |
376: Increased, Induced Mutations in Critical Genes |
491: Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF) |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 550 |
491: Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF) |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 551 |
373: Formation, Pro-mutagenic DNA Adducts |
491: Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF) |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 634 |
618: Decreased, Neuronal network function in adult brain |
341: Impairment, Learning and memory |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 647 |
352: N/A, Neurodegeneration |
618: Decreased, Neuronal network function in adult brain |
Nov 29, 2016 |
Nov 29, 2016 |
2 AOPs
|
| 864 |
844: Oxidation, Uroporphyrinogen |
846: Accumulation, Highly carboxylated porphyrins |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 867 |
845: Inhibition, UROD |
844: Oxidation, Uroporphyrinogen |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 874 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
853: Changes/Inhibition, Cellular Homeostasis and Apoptosis |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 875 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
854: Alterations, Cellular proliferation / hyperplasia |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 876 |
165: Activation, Long term AHR receptor driven direct and indirect gene expression changes |
856: Formation, Hepatocellular and Bile duct tumors |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 877 |
857: Binding as antagonist, Antagonist binding to PPARalpha ligand binding domain |
858: Decreased, PPARalpha transactivation of gene expression |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 881 |
859: Decreased, Peroxisomal Fatty Acid Beta Oxidation of Fatty Acids |
860: Decreased, Mitochondrial Fatty Acid Beta Oxidation |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 882 |
860: Decreased, Mitochondrial Fatty Acid Beta Oxidation |
861: Decreased, Ketogenesis (production of ketone bodies) |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 886 |
867: Decrease, Intracellular pH |
768: Increase, Cytotoxicity |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 887 |
768: Increase, Cytotoxicity |
868: Increase, Tissue Degeneration, Necrosis & Atrophy |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 916 |
901: Infiltration, Inflammatory cells |
902: Inflammation, Liver |
Nov 29, 2016 |
Nov 29, 2016 |
None
|